NS-2028

Research use only, not for human use.

NS-2028 is a highly selective soluble Guanylyl Cyclase (sGC) inhibitor (IC50: 30 nM and 200 nM for basal and NO-stimulated enzyme activity).

NS-2028 is a highly selective soluble Guanylyl Cyclase (sGC) inhibitor (IC50: 30 nM and 200 nM for basal and NO-stimulated enzyme activity). It is commonly used in the research of nitric oxide signaling pathways. NS-2028 inhibits soluble Guanylyl Cyclase activity in homogenates of mouse cerebellum and neuronal NO synthase (IC50: 17 nM and 20 nM). NS-2028 inhibits 3-morpholino-sydnonimine (SIN-1)-elicited formation of cyclic GMP in human cultured umbilical vein endothelial cells (IC50: 30 nM). NS-2028 inhibits NO-dependent relaxant responses in non-vascular smooth muscle completely (1 μM). NS-2028 decreases vascular endothelial growth factor-induced angiogenesis and permeability.

Cell Proliferation Assay Cell Line:HUVEC cells Concentration:10 μM Incubation Time:24 hours Result:Decreased cell numbers in culture.Western Blot Analysis Cell Line:HUVEC cells Concentration:10 μM Incubation Time:30 mins Result:Attenuated VEGF-enhanced p38 phosphorylation.

Animal Model:Rabbit Dosage:1 g/L Administration:Deliver orally; 1g/L; 8 days Result:Inhibits VEGF-induced angiogenesis in vivo.

——

Others

Other Targets

sGC

——

——

204326-43-2

269.05

C9H5BrN2O3

>98% (HPLC)

DMSO: 250 mg/mL (929.20 mM; Need ultrasonic)

O=C1ON=C2COC3=CC=C(Br)C=C3N21

——

(-20℃)

With Ice Pack

≥ 2 years